Patong, Enelyn M.
HRN: 10-03-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2022
MUPIROCIN 2%, 15G (TUBE)
11/25/2022
11/30/2022
TOPICAL
2%
BID
S/P Excision Of Epidermal Inclusion Cyst
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes